Kathryn Ciccolini on the Increase of Dermatologic AE's With New Cancer Therapies

May 27, 2016
Kathryn Ciccolini, RN, BSN, OCN, DNC

Kathryn Ciccolini, RN, BSN, OCN, DNC, Memorial Sloan Kettering Cancer Center, discusses the increase of dermatologic adverse events with new cancer therapies.

Kathryn Ciccolini, RN, BSN, OCN, DNC, Memorial Sloan Kettering Cancer Center, discusses the increase of dermatologic adverse events with new cancer therapies.

With new cancer treatments including immunotherapy and targeted therapy comes more dermatologic adverse events for patients on these treatments. Ciccolini emphasized the importance of referring patients on these therapies to a dermatologic specialist for assessment, education, and planning.